Looking at itrack placement presentation in May 23, the market projection for Global Canal Surgery procedure for 2024 is about 380k at roughly $500 per procedure. If Itrack market share is 10% it is 38K sales @ $200 each (assuming it is 40:60 split for device and procedure fee), then sales $ is only $7.6Mil, so to get to $20mil revenue they need market share of 30%? Any thoughts or comments on this?
Nova Eye Medical (EYE) Discussion, page-2033
-
- There are more pages in this discussion • 1,155 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
0.005(3.45%) |
Mkt cap ! $34.35M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.0¢ | 14.5¢ | $16.57K | 113.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 125700 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 64039 | 3 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| EYE (ASX) Chart |